American College of Rheumatology Poster Presentation Highlights Clinical Data About bosentan In Systemic Sclerosis Patients Suffering From Digital Ulceration
November 16, 2005 01:00 ET
|
Actelion Ltd.
SAN DIEGO, Nov. 16, 2005 (PRIMEZONE) -- Actelion Ltd (Other OTC:ATLN) announced today the poster presentation at the American College of Rheumatology (ACR) of results of RAPIDS-2, a...
First Ever Placebo-Controlled Trial to Show Benefits in Eisenmenger's Syndrome Presented at CHEST
November 01, 2005 01:00 ET
|
Actelion Ltd.
MONTREAL, Nov. 1, 2005 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) (Other OTC:ALIOF) announced that the results from the first ever placebo-controlled study in patients with Eisenmenger's syndrome are...
One-Year Results on the Use of Miglustat -- Zavesca -- in Niemann Pick Type C Presented at the Annual Conference of the American Society of Human Genetics
October 26, 2005 20:00 ET
|
Actelion Ltd.
ALLSCHWIL, Switzerland, Oct. 26, 2005 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) (Other OTC:ALIOF) announced today a poster presentation at the annual conference of the American Society of Human Genetics...
CORRECTING and REPLACING -- Actelion Announces 9-Month Results for 2005
October 19, 2005 20:14 ET
|
Actelion Ltd.
ALLSCHWIL, Switzerland, Oct. 19, 2005 (PRIMEZONE) -- Due to a transposition error, the Actelion 9-months 2005 press release contained two errors in terms of Tracleer sales numbers. Tracleer sales for...
Actelion Announces 9-Month Results for 2005
October 19, 2005 11:55 ET
|
Actelion Ltd.
ALLSCHWIL, Switzerland, Oct. 19, 2005 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) today announced its financial results for the first nine months of 2005. With total net revenues for the first nine months...
Actelion Hosts its 3rd Research and Development Day
September 08, 2005 01:00 ET
|
Actelion Ltd.
ALLSCHWIL, Switzerland, Sept. 8, 2005 (PRIMEZONE) -- Actelion Ltd. (SWX:ATLN) (Other OTC:ALIOF) today provided a comprehensive overview of its preclinical and clinical pipeline at its 3rd R&D...
Tracleer Excellence Post Marketing Surveillance Programme -- TRAX PMS -- Confirms Long-Term Safety Profile in Various Pulmonary Arterial Hypertension Subgroups
September 05, 2005 01:03 ET
|
Actelion Ltd.
STOCKHOLM, Sweden, Sept. 5, 2005 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) announced today that two abstracts presented at the European Society of Cardiology (ESC) conference confirm the long-term...
Actelion Ltd.: JACC Publication on Tracleer in Children with PAH
August 16, 2005 11:35 ET
|
Actelion Ltd.
ALLSCHWIL, Switzerland, Aug. 16, 2005 (PRIMEZONE) -- Actelion Ltd. (Other OTC:ALIOF) (SWX:ATLN) announced today that the Journal of the American College of Cardiology (JACC) has published a new study...
Actelion: Second Study with bosentan (Tracleer) Demonstrating a Statistically Significant Reduction of New Digital Ulcers in Patients with Systemic Sclerosis
August 09, 2005 01:00 ET
|
Actelion Ltd.
ALLSCHWIL, Switzerland, Aug. 9, 2005 (PRIMEZONE) -- Actelion Ltd (Other OTC:ALIOF) (SWX: ATLN) announced today the preliminary result of a double-blind, placebo-controlled, randomized, multi-center,...
Actelion Announces Half-Year Financial Results 2005
July 28, 2005 01:16 ET
|
Actelion Ltd.
ALLSCHWIL/BASEL, Switzerland, July 28, 2005 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) (Other OTC:ALIOF) today announced its financial results for the first six months of 2005. With total net revenue for...